Shield Therapeutics plc (AIM:STX)
London · Delayed Price · Currency is GBP · Price in GBX 3.650
-0.050 (-1.35%)
Jul 16, 2025, 4:35 PM GMT+1
Shield Therapeutics Market Cap
Shield Therapeutics has a market cap or net worth of 38.54 million as of July 16, 2025. Its market cap has increased by 181.62% in one year.
Market Cap
38.54M
Enterprise Value
54.39M
Revenue
25.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.65
Market Cap Chart
Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 38.54M, a decrease of -77.30%. That is a compound annual growth rate of -14.61%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 165.33B |
| GSK plc | 56.99B |
| Haleon | 33.01B |
| Smith & Nephew | 9.82B |
| ConvaTec Group | 5.33B |
| Hikma Pharmaceuticals | 4.32B |
| HUTCHMED (China) | 2.02B |
| Oxford Nanopore Technologies | 1.47B |